Filtered By:
Vaccination: Rubella Vaccine
Countries: China Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 24 results found since Jan 2013.
Prevalence of preconception TORCH infections and its influential factors: evidence from over 2 million women with fertility desire in southern China
CONCLUSION: The findings of this study update the baseline of preconception TORCH infections among women with fertility desire in southern China, helping to estimate the risk of congenital infection and guide the development and implementation of effective prevention measures for preconception TORCH infections.PMID:37563634 | DOI:10.1186/s12905-023-02560-4
Source: Herpes - August 10, 2023 Category: Infectious Diseases Authors: Lu Han Rui Li Wenxue Xiong Yang Hu Jiabao Wu Xiaohua Liu Hua Nie Weibing Qin Li Ling Mingzhen Li Source Type: research
Molecular surveillance of rubella virus in Beijing, China during 2010-2021: Progress and challenges in rubella elimination
Vaccine. 2022 Oct 17:S0264-410X(22)01217-8. doi: 10.1016/j.vaccine.2022.09.084. Online ahead of print.ABSTRACTRubella is listed by the World Health Organization (WHO) as a disease that needs to be eliminated worldwide. The aim of this study was to understand the progress and challenges towards rubella elimination in Beijing, China, by analyzing molecular surveillance data combined with immunization and surveillance strategies as well as epidemiological data. With high immunization coverage under the 3-dose policy (8 months, 18 months, and 6 years) and supplementary immunization activities for the floating population, rubel...
Source: Vaccine - October 20, 2022 Category: Allergy & Immunology Authors: Xiali Yu Luodan Suo Wei Li Weixin Chen Dan Zhao Jingbin Pan Li Lu Xiaoqun Mu Fang Huang Meng Chen Zhen Zhu Source Type: research
The epidemiology and disease burden of congenital TORCH infections among hospitalized children in China: A national cross-sectional study
CONCLUSION: In the present study, the hospitalization proportion due to congenital TORCH infection was extremely low (17.56 per 100,000 neonates), indicating that China's congenital TORCH infection prevention and control policies remain effective. The lowest proportion of patients was hospitalized with congenital toxoplasmosis, while the LOS was the longest. The economic burden of CRS was heavy, and infants are recommended be vaccinated against RV in a timely manner. Congenital CMV infections accounted for the largest proportion of patients, suggesting that the disease burden of congenital CMV infection cannot be ignored, ...
Source: Herpes - October 14, 2022 Category: Infectious Diseases Authors: Linlin Zhang Xinyu Wang Mengjia Liu Guoshuang Feng Yueping Zeng Ran Wang Zhengde Xie Source Type: research
Immunogenicity and safety of the inactivated enterovirus 71 vaccine administered concomitantly with the measles-rubella vaccine in infants aged 8 months in China: A noninferiority randomized controlled trial
CONCLUSION: Antibody responses induced by simultaneous administration of EV71 vaccine with MR vaccine were robust and noninferior to those by single administration alone. Like the previous findings by single administration alone, simultaneous administration demonstrated comparable reactogenicity and safety profiles.PMID:35753838 | DOI:10.1016/j.vaccine.2022.06.027
Source: Vaccine - June 26, 2022 Category: Allergy & Immunology Authors: Zhimei Zhao Yuyi Liao Yuan Li Guorun Jiang Zhuhang Huang Huijuan Yang Zhiqiang Ou Qiongzhou Yin Junhu Chen Yan Deng Ruiju Jiang Yanchun Che Qihan Li Huizhen Zheng Jikai Zhang Source Type: research
Intelligent system based comparative analysis study of SARS-CoV-2 spike protein and antigenic proteins in different types of vaccines
CONCLUSIONS: Our in silico study suggests a possible protective effect of Poliovirus, HIB, Hepatitis B, PCV10, Measles, Mumps, and Rubella (MMR) vaccines against COVID-19.PMID:35284579 | PMC:PMC8899449 | DOI:10.1186/s43088-022-00216-0
Source: Appl Human Sci - March 14, 2022 Category: Physiology Authors: Rabeb Touati Ahmed A Elngar Source Type: research
Vaccines for measles, mumps, rubella, and varicella in children
CONCLUSIONS: Existing evidence on the safety and effectiveness of MMR/MMRV vaccines support their use for mass immunisation. Campaigns aimed at global eradication should assess epidemiological and socioeconomic situations of the countries as well as the capacity to achieve high vaccination coverage. More evidence is needed to assess whether the protective effect of MMR/MMRV could wane with time since immunisation.PMID:34806766 | DOI:10.1002/14651858.CD004407.pub5
Source: Cochrane Database of Systematic Reviews - November 22, 2021 Category: General Medicine Authors: Carlo Di Pietrantonj Alessandro Rivetti Pasquale Marchione Maria Grazia Debalini Vittorio Demicheli Source Type: research
Seroepidemiology of TORCH Infections among 1.7 Million Women of Childbearing Age in Rural China: A Population-Based Cross-Sectional Study
Am J Trop Med Hyg. 2021 Sep 20:tpmd200137. doi: 10.4269/ajtmh.20-0137. Online ahead of print.ABSTRACTWe conducted a national seroepidemiological study of the TORCH (Toxoplasma gondii [TOX], Rubella [RV], Cytomegalovirus [CMV], and Herpes Simplex Virus) in rural women to provided updated baseline data on TORCH prevalence. A total of 1,541,329 women of childbearing age were gathered from 2010 to 2012 in China. Of these, 858,072 women were tested positive for anti-RV IgG antibodies, 602,251 women were tested positive for anti-CMV antibodies, and 40,055 women were tested positive for anti-TOX antibodies. TORCH prevalence was h...
Source: The American Journal of Tropical Medicine and Hygiene - September 20, 2021 Category: Tropical Medicine Authors: Xiaosong Qin Shikun Zhang Hongbo Liu Guixue Cheng Yong Liu Mei Hu Na Liu Man Zhang Source Type: research
